Analysis of Suspension of Clinical Trials for Drug Registration in China

• Auteurs principaux: Xian Su (Auteur), Xiaocong Pang (Auteur), Xin Zeng (Auteur), Yi Gao (Auteur), Yimin Cui (Auteur), Haixue Wang (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Suspension is an important risk control measure during clinical trials. We investigated the use of this in China and identified common reasons for suspension by analyzing trends, hold issues, outcomes, background and design characteristics of suspended clinical drug trials from January 1, 2013 to De...